Effects of Mobility-Enhancing Nursing Intervention in Patients with MS and Stroke: Randomised Controlled Trial

Lorenz Imhof, Susanne Suter-Riederer, Jürg Kesselring, Lorenz Imhof, Susanne Suter-Riederer, Jürg Kesselring

Abstract

Background. Multiple sclerosis (MS) or stroke causes functional impairment which can have a major impact on patients' life. Objectives. This RCT investigated the effect of a new nursing intervention (Mobility Enhancing Nursing Intervention-MFP) designed to improve rehabilitation outcomes. Method. The study took place in a rehabilitation clinic in Switzerland. One hundred forty participants diagnosed with MS, stroke, and brain injuries were randomly assigned to control group (CG = standard care) or intervention group (IG). The IG combined standard care with 30 days of MFB. MFP placed patients on a mattress on the floor and used tactile-kinaesthetic stimulation to increase spatial orientation and independency. Outcomes were functionality (Extended Barthel Index, EBI), quality of life (WHOQoL), and fall-related self-efficacy (FES-I). Results. There was a significant main effect of the intervention on functionality (EBI-diff/day mean = 0.30, versus mean = 0.16, P = 0.008). There was also a significant main effect on QoL (WHOQoL-diff mean = 13.8, versus mean = 5.4, P = 0.046). No significant effect was observed on fall-related self-efficacy. Conclusions. The positive effect of MFP on rehabilitation outcomes and quality of life suggests that this specialized nursing intervention could become an effective part of rehabilitation programs. The study was approved by the Ethics Committee of St. Gallen (KEK-SG Nr. 09/021) and registered at ClinicalTrial.gov NCT02198599.

Figures

Figure 1
Figure 1
Recruitment process.

References

    1. Kesselring J., Comi G., Thompson A. J. Recovery of Function and Neurorehabilitation in Multiple Sclerosis. Cambridge, UK: Cambridge University Press; 2010.
    1. Khan F., Turner-Stokes L., Ng L., Kilpatrick T. Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Systematic Reviews. 2007;(2) doi: 10.1002/14651858.CD006036.pub2.CD006036
    1. Kesselring J., Beer S. Symptomatic therapy and neurorehabilitation in multiple sclerosis. The Lancet Neurology. 2005;4(10):643–652. doi: 10.1016/s1474-4422(05)70193-9.
    1. Courts N. F., Buchanan E. M., Werstlein P. O. Focus groups: the lived experience of participants with multiple sclerosis. Journal of Neuroscience Nursing. 2004;36(1):42–47. doi: 10.1097/01376517-200402000-00007.
    1. Beer S., Khan F., Kesselring J. Rehabilitation interventions in multiple sclerosis: an overview. Journal of Neurology. 2012;259(9):1994–2008. doi: 10.1007/s00415-012-6577-4.
    1. Suter-Riederer S., Mahrer-Imhof R., Kesseiring J., Imhof L. ‘Bodenpflege’ für agitierte Menschen nach Hirnverletzung. Neurologie & Rehabilitation. 2008;14(2):70–78.
    1. Suter-Riederer S., Valär C., Imhof L. Körperwahrnehmung vermittelt Wirklichkeit und steigert die Lebensqualität. Lebensqualität-Die Zeitschrift für Kinaestetics. 2009;2:31–38.
    1. Hatch F., Maietta L., Schmidt S. Kinästhetik: Interaktion durch Berührung und Bewegung in der Pflege. Bad Soden, Germany: DBFK; 2005.
    1. Assmussen M. Praxisbuch Kinästhetics. Jena, Germany: Urban & Fischer; 2006.
    1. Doran D. M. Functional status. In: Doran D. M., editor. Nursing-Sensitive Outcomes: State of the Science. Sudbury, Mass, USA: Jones and Bartlett; 2003. pp. 27–64.
    1. Janša J., Pogačnik T., Gompertz P. An evaluation of the Extended Barthel Index with acute ischemic stroke patients. Neurorehabilitation and Neural Repair. 2004;18(1):37–41. doi: 10.1177/0888439003262287.
    1. Marolf M. V., Vaney C., König N., Schenk T., Prosiegel M. Evaluation of disability in multiple sclerosis patients: a comparative study of the functional independence measure, the extended barthel index and the expanded disability status scale. Clinical Rehabilitation. 1996;10(4):309–313. doi: 10.1177/026921559601000408.
    1. Prosiegel M., Böttiger S., Schenk T., et al. Der erweiterte Barthel-Index (EBI): eine Skala zur Erfassung von Fähigkeitsstörungen bei neurologishcen Patienten. Neurologie & Rehabilitation. 1996;1:7–13.
    1. Hunstein D., Fiebig M. Klinische Testung des ePA-AC: Erste Ergebnisse. Wiesbaden, Germany: ePA-Competence-Center; 2006.
    1. Fiebig M., Hunstein D. Testung der Interrater-Reliabilitätdes ergebnisorientierten PflegeAssessments AcuteCare (ePA-AC) 2006.
    1. Hunstein D. Handbuch ergebnisorientiertes PflegeAssessment AcuteCare ePA_AC. Wiesbaden, Germany: ePA-Competence-Center; 2009.
    1. Schmidt S. Expertenstandards in der Pflege: Eine Gebrauchsanleitung. Berlin, Germany: Springer; 2009. Nationaler expertenstandard entlassungsmanagement in der pflege; pp. 33–45.
    1. Angermeyer M. C., Kilian R., Matschinger H. WHOQOL-100 und WHOQOL-BREF. Handbuch für die deutsche Version der WHO Instrumente zur Erfassung von Lebensqualität. Göttingen, Germany: Hogrefe; 2000.
    1. Kempen G. I. J. M., Yardley L., van Haastregt J. C. M., et al. The short FES-I: a shortened version of the falls efficacy scale-international to assess fear of falling. Age and Ageing. 2008;37(1):45–50. doi: 10.1093/ageing/afm157.
    1. van Vliet R., Hoang P., Lord S., Gandevia S., Delbaere K. Falls efficacy scale-international: a cross-sectional validation in people with multiple sclerosis. Archives of Physical Medicine and Rehabilitation. 2013;94(5):883–889. doi: 10.1016/j.apmr.2012.10.034.
    1. Bula C. J., Martin E., Rochat S., Piot-Ziegler C. Validation of an adapted falls efficacy scale in older rehabilitation patients. Archives of Physical Medicine and Rehabilitation. 2008;89(2):291–296.
    1. Dias N., Kempen G. I. J. M., Todd C. J., et al. The German version of the falls efficacy scale-international version (FES-I) Zeitschrift fur Gerontologie und Geriatrie. 2006;39(4):297–300. doi: 10.1007/s00391-006-0400-8.
    1. Cameron M., Finlayson M., Kesselring J. Multiple sclerosis basics. In: Finlayson M., editor. Multiple Sclerosis Rehabilitation: From Impairment to Participation. Boca Raton, Fla, USA: CRC Press; Taylor & Francis Group; 2013. pp. 9–34.
    1. Dromerick A. W., Edwards D. F., Diringer M. N. Sensitivity to changes in disability after stroke: a comparison of four scales useful in clinical trials. Journal of Rehabilitation Research and Development. 2003;40(1):1–8. doi: 10.1682/jrrd.2003.01.0001.
    1. Özakbas S., Akdede B. B., Kösehasanogullari G., Aksan Ö., Idiman E. Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy. Journal of the Neurological Sciences. 2007;256(1-2):30–34. doi: 10.1016/j.jns.2007.01.080.
    1. de Souza A. C. D., da Costa Rocha M. O., Teixeira A. L., Dias Júnior J. O., de Sousa L. A. P., Nunes M. C. P. Depressive symptoms and disability in chagasic stroke patients: impact on functionality and quality of life. Journal of the Neurological Sciences. 2013;324(1-2):34–37. doi: 10.1016/j.jns.2012.09.022.
    1. Rosén E., Sunnerhagen K. S., Kreuter M. Fear of falling, balance, and gait velocity in patients with stroke. Physiotherapy Theory and Practice. 2005;21(2):113–120. doi: 10.1080/09593980590922299.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel